Fox Business - The Power to Prosper
Search Site

Novartis

The latest drugs being tested to fight melanoma

Array BioPharma CEO Ron Squarer on the latest treatments tested in the pharmaceutical industry to battle cancer.

Read More

  1. World Economic Forum awaits ECB QE decision

    FBN’s Liz Claman with the latest on the World Economic Forum in Davos, Switzerland.

  2. U.S. stocks rise for third-straight session

    Claman on Call: FBN’s Cheryl Casone with an after-hours web exclusive on the overseas markets, eBay’s fourth-quarter results and the latest from Davos.

  3. What will be discussed at the World Economic Forum?

    FBN’s Liz Claman with the latest on the World Economic Forum in Davos, Switzerland.

  4. Eli Lilly CEO: 2015 is a key transition year for us

    Eli Lilly CEO John Lechleiter discusses new products, 2015 outlook, its Alzheimer’s disease program and animal health division.

  5. Stocks to fall 25%?

    WSJ Sunday Personal Finance Columnist Jonathan Clements on the benefits of a potential pullback in the markets and strategies for re-allocating your portfolio.

  6. How Novartis is revolutionizing the pharma landscape

    Claman on Call: FBN’s Liz Claman with an after-hours web exclusive on the markets, the midterm elections, Novartis ’ on the brink of treatments for cancer and heart failure and the earnings to watch for tomorrow.

  7. New Hampshire, North Carolina the bellwethers for GOP?

    Former Kansas Governor Mark Parkinson and Former Maryland Governor Robert Ehrlich say the key races for Republicans are New Hampshire and North Carolina.

  8. Novartis CEO: Working on a cure for cancer

    Novartis CEO Joseph Jimenez says the company is working on finding a cure for cancer and bringing a revolutionary heart drug to market by 2015.

  9. Cost of cancer treatments

    Radiation oncologist Dr. Elizabeth Chabner Thompson on the high price tags in the fight against cancer.

  10. Get help in the kitchen from Boris the Robot

    The Real Housewives of New York City's Heather Thomson and The Wall Street Journal’s Veronica Dagher on the new robot that could help you with the dishes and a Dutch teen's unique drone.

  11. Novartis study finds heart failure drug cut cardiovascular deaths

    FBN’s Lauren Simonetti on Compuware and Novartis ’ new heart failure drug.

  12. Lilly CEO sees margins hitting pre-patent cliff levels by ‘19

    Eli Lilly CEO John Lechleiter discusses 2Q earnings and the impact of recent patent expirations.

  1. Lower expectations for 1Q earnings?

    Weatherstone Capital Management Portfolio Manager Michael Ball, Bryn Mawr Trust CIO Ernie Cecilia and Bulls-eye Options Chief Strategist Alan Knuckman on the outlook for the markets.

  2. The big business of vaccines

    FBN’s Peter Barnes on the big, and growing, vaccine industry.

  3. Investing in European stocks

    Live at the World Money Show, FBN’s Charles Payne, Fabian Wealth Strategies’ Chris Versace and Penn Financial Group founder Matt McCall answer an audience question about European stocks.

  4. Katy Perry’s halftime show a success?

    The Hollywood and Vine panel weighs in on Katy Perry’s halftime performance, Gwyneth Paltrow, Suge Knight and Tom Brady.

  5. U.S. stocks enjoy ECB-fueled rally

    Claman on Call: FBN’s David Asman with an after-hours web exclusive on the markets, the Patriots scandal and the latest from Davos.

  6. Novartis CEO: New heart drug will be a blockbuster

    Novartis CEO Joseph Jimenez discusses how the Swiss Franc decision affected business, the company’s new heart failure drug, and the ECB’s QE decision.

  7. Big names arrive in the Swiss Alps

    FBN’s Liz Claman with the latest on the World Economic Forum and a look at Swiss chocolates.

‹ Prev12345Next ›
Freebase CC-BY
Source: Novartis on Freebase, licensed under CC-BY
Other content from Wikipedia, licensed under the GFDL